-
Clinical trials in pediatrics
Anne B Chang, Kerry-Ann F OGrady
Editorial: Clinical Investigation
-
Clinical trials in pediatrics
Anne B Chang, Kerry-Ann F OGrady
Editorial: Clinical Investigation
-
Clinical trials in pediatrics
Anne B Chang, Kerry-Ann F OGrady
Editorial: Clinical Investigation
-
Clinical trials in pediatrics
Anne B Chang, Kerry-Ann F OGrady
Editorial: Clinical Investigation
-
Clinical trials in pediatrics
Anne B Chang, Kerry-Ann F OGrady
Editorial: Clinical Investigation
-
Clinical trials in pediatrics
Anne B Chang, Kerry-Ann F OGrady
Editorial: Clinical Investigation
-
Clinical trials in pediatrics
Anne B Chang, Kerry-Ann F OGrady
Editorial: Clinical Investigation
-
Clinical trials in pediatrics
Anne B Chang, Kerry-Ann F OGrady
Editorial: Clinical Investigation
-
Agalsidase alfa for the treatment of fabry disease: a closer look
Shawn E Lipinski, Edina Komlodi-Pasztor & Ozlem Goker-Alpan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Agalsidase alfa for the treatment of fabry disease: a closer look
Shawn E Lipinski, Edina Komlodi-Pasztor & Ozlem Goker-Alpan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Agalsidase alfa for the treatment of fabry disease: a closer look
Shawn E Lipinski, Edina Komlodi-Pasztor & Ozlem Goker-Alpan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Agalsidase alfa for the treatment of fabry disease: a closer look
Shawn E Lipinski, Edina Komlodi-Pasztor & Ozlem Goker-Alpan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Agalsidase alfa for the treatment of fabry disease: a closer look
Shawn E Lipinski, Edina Komlodi-Pasztor & Ozlem Goker-Alpan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Agalsidase alfa for the treatment of fabry disease: a closer look
Shawn E Lipinski, Edina Komlodi-Pasztor & Ozlem Goker-Alpan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Agalsidase alfa for the treatment of fabry disease: a closer look
Shawn E Lipinski, Edina Komlodi-Pasztor & Ozlem Goker-Alpan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Agalsidase alfa for the treatment of fabry disease: a closer look
Shawn E Lipinski, Edina Komlodi-Pasztor & Ozlem Goker-Alpan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
An update on the management of comorbid conditions in lupus nephritis
Vassiliki Tzavara, Cristina Pamfil, Dimitrios T Boumpas, George K Bertsias
Review: Clinical Trail Outcomes: Clinical Investigation
-
An update on the management of comorbid conditions in lupus nephritis
Vassiliki Tzavara, Cristina Pamfil, Dimitrios T Boumpas, George K Bertsias
Review: Clinical Trail Outcomes: Clinical Investigation
-
An update on the management of comorbid conditions in lupus nephritis
Vassiliki Tzavara, Cristina Pamfil, Dimitrios T Boumpas, George K Bertsias
Review: Clinical Trail Outcomes: Clinical Investigation
-
An update on the management of comorbid conditions in lupus nephritis
Vassiliki Tzavara, Cristina Pamfil, Dimitrios T Boumpas, George K Bertsias
Review: Clinical Trail Outcomes: Clinical Investigation
-
An update on the management of comorbid conditions in lupus nephritis
Vassiliki Tzavara, Cristina Pamfil, Dimitrios T Boumpas, George K Bertsias
Review: Clinical Trail Outcomes: Clinical Investigation
-
An update on the management of comorbid conditions in lupus nephritis
Vassiliki Tzavara, Cristina Pamfil, Dimitrios T Boumpas, George K Bertsias
Review: Clinical Trail Outcomes: Clinical Investigation
-
An update on the management of comorbid conditions in lupus nephritis
Vassiliki Tzavara, Cristina Pamfil, Dimitrios T Boumpas, George K Bertsias
Review: Clinical Trail Outcomes: Clinical Investigation
-
An update on the management of comorbid conditions in lupus nephritis
Vassiliki Tzavara, Cristina Pamfil, Dimitrios T Boumpas, George K Bertsias
Review: Clinical Trail Outcomes: Clinical Investigation
-
Oral antiplatelet agents in ischemic heart disease: a review of the latest clinical evidence
Nadia Paarup Dridi, Lene Holmvang, Peter Clemmensen
Review Article: Clinical Investigation
-
Oral antiplatelet agents in ischemic heart disease: a review of the latest clinical evidence
Nadia Paarup Dridi, Lene Holmvang, Peter Clemmensen
Review Article: Clinical Investigation
-
Oral antiplatelet agents in ischemic heart disease: a review of the latest clinical evidence
Nadia Paarup Dridi, Lene Holmvang, Peter Clemmensen
Review Article: Clinical Investigation
-
Oral antiplatelet agents in ischemic heart disease: a review of the latest clinical evidence
Nadia Paarup Dridi, Lene Holmvang, Peter Clemmensen
Review Article: Clinical Investigation
-
Oral antiplatelet agents in ischemic heart disease: a review of the latest clinical evidence
Nadia Paarup Dridi, Lene Holmvang, Peter Clemmensen
Review Article: Clinical Investigation
-
Oral antiplatelet agents in ischemic heart disease: a review of the latest clinical evidence
Nadia Paarup Dridi, Lene Holmvang, Peter Clemmensen
Review Article: Clinical Investigation
-
Oral antiplatelet agents in ischemic heart disease: a review of the latest clinical evidence
Nadia Paarup Dridi, Lene Holmvang, Peter Clemmensen
Review Article: Clinical Investigation
-
Oral antiplatelet agents in ischemic heart disease: a review of the latest clinical evidence
Nadia Paarup Dridi, Lene Holmvang, Peter Clemmensen
Review Article: Clinical Investigation